1. 抗体
  2. 一抗
  3. 多克隆抗体 流式抗体
  4. Parkin 抗体

Parkin Antibody 是一个兔来源、无偶联标记、抗 Parkin 的 IgG 多克隆抗体。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
20 μL ¥846 In-stock
50 μL ¥1220 In-stock
100 μL ¥2000 In-stock
250 μL   询价  

* Please select Quantity before adding items.

  • WB: 蛋白质免疫印迹;
  • IHC-P: 石蜡切片样本的免疫组织化学;
  • IHC-F: 冰冻切片样本的免疫组织化学;
  • ICC/IF: 细胞免疫荧光;
  • IF-Tissue: 组织免疫荧光;
  • mIHC: 多重荧光免疫组化;
  • IP: 免疫沉淀;
  • ChIP: 染色质免疫沉淀;
  • FC: 流式细胞术;
  • ELISA: 酶联免疫吸附试验
  • 产品详情

  • 验证图片

  • 背景信息

  • 产品资料

描述

Parkin Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to Parkin.

宿主

Rabbit

克隆性

Polyclonal

分子量
Predicted band size: 52 kDa;
Observed band size: 52 kDa
请注意:因蛋白存在修饰或聚体等情况,以实测为准,预测仅为参考。
反应种属
Human, Mouse, Rat
蛋白数据库
基因 ID
免疫原

Synthetic peptide corresponding to Human Parkin aa5-56.

应用 & 推荐
稀释比例
应用 稀释比
WB
WB: 蛋白质免疫印迹
1:500-1:1000
IHC-P
IHC-P: 石蜡切片样本的免疫组织化学
1:50-1:100
ICC/IF
ICC/IF: 细胞免疫荧光
1:50-1:200
IP
IP: 免疫沉淀
1:20
FC
FC: 流式细胞术
1:50-1:100
敏感性 Endogenous 纯度 affinity purified
偶联 Non-conjugated 修饰 Unmodified
同型 IgG  
性状

液体

组分

Supplied in Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.

保存条件 & 期限

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

运输条件

Shipping with blue ice.

验证图片
ALL WB ICC IHC-P FC
  • Western blot analysis of extracts from KHEK293T(lane 2(20μg) , Neuro-2a(lane 3(20ug) and C6(lane 4(20μg) using Parkin Antibody (HY-P80779) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

  • Immunocytochemistry analysis of SH-SY5Y cells labeling Parkin with Parkin Antibody (HY-P80779) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Parkin Antibody (HY-P80779) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • Immunocytochemistry analysis of C6 cells labeling Parkin with Parkin Antibody (HY-P80779) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Parkin Antibody (HY-P80779) at 1/100 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).

  • Immunohistochemical analysis of paraffin-embedded mouse testis tissue using Parkin Antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody at 1/100 dilution in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

  • Immunohistochemical analysis of paraffin-embedded mouse testis tissue using Parkin Antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody at 1/100 dilution in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.

  • Flow cytometric analysis of 1X10^6 SH-SY5Y cells labeling Parkin Antibody (HY-P80779, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/50 dilution for an hour at 4℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L (HY-P8002) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Rabbit IgG Isotype Control (HY-P80879, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

背景
功能:在多蛋白 E3 泛素连接酶复合物中发挥作用,催化泛素部分与底物蛋白的共价连接 (PubMed:10888878, PubMed:10973942, PubMed:11431533, PubMed:12150907, PubMed:12628165, PubMed:15105460, PubMed:16135753, PubMed:21376232, PubMed:21532592, PubMed:22396657, PubMed:23620051, PubMed:23754282, PubMed:24660806, PubMed:24751536, PubMed:29311685, PubMed:32047033)。底物包括 SYT11 和 VDAC1 (PubMed:29311685, PubMed:32047033)。其他底物包括 BCL2、CCNE1、GPR37、RHOT1/MIRO1、MFN1、MFN2、STUB1、SNCAIP、SEPTIN5、TOMM20、USP30、ZNF746、MIRO1 和 AIMP2 (PubMed:10888878、PubMed:10973942、PubMed:11431533、PubMed:12150907、PubMed:12628165、PubMed:15105460、PubMed:16135753、PubMed:21376232、PubMed:21532592、PubMed:22396657、PubMed:23620051、PubMed:23754282)。 PubMed:24660806, PubMed:24751536)。介导底物的单泛素化以及“Lys-6”、“Lys-11”、“Lys-48”连接和“Lys-63”连接的多泛素化,具体取决于上下文 (PubMed:19229105, PubMed:20889974, PubMed:25474007, PubMed:25621951, PubMed:32047033)。通过介导错误折叠蛋白 (如 PARK7) 的“Lys-63”连接的多聚泛素化,参与异常折叠或受损蛋白的清除和/或解毒:“Lys-63”连接的多聚泛素化错误折叠蛋白随后被 HDAC6 识别,导致它们被募集到聚集体,然后被降解 (PubMed:17846173,PubMed:19229105)。介导 SNCAIP 22 kDa O-连接糖基化异构体的“Lys-63”连接的多聚泛素化,可能在路易体形成中发挥作用 (PubMed:11431533, PubMed:11590439, PubMed:15105460, PubMed:15728840, PubMed:19229105)。介导 BCL2 的单泛素化,从而作为自噬的正向调节因子 (PubMed:20889974)。在细胞应激期间,通过作用于 PINK1 的下游,协调线粒体质量控制机制,清除和替换功能异常的线粒体成分,从而保护细胞免受线粒体功能障碍的影响 (PubMed:11439185, PubMed:18957282, PubMed:19029340, PubMed:19966284, PubMed:21376232, PubMed:22082830, PubMed:22396657, PubMed:23620051, PubMed:23933751, PubMed:24660806, PubMed:24784582, PubMed:24896179, PubMed:25474007, PubMed:25527291)。 PubMed:32047033)。根据线粒体损伤和/或功能障碍的严重程度,其活性范围从防止细胞凋亡和刺激线粒体生物合成到调节线粒体动力学以及通过线粒体自噬清除严重受损的线粒体 (PubMed:11439185, PubMed:19029340, PubMed:19801972, PubMed:19966284, PubMed:21376232, PubMed:22082830, PubMed:22396657, PubMed:23620051, PubMed:23685073, PubMed:23933751, PubMed:24896179, PubMed:25527291, PubMed:32047033)。 PubMed:33499712)。PRKN 和泛素的激活和募集到受损/功能障碍线粒体外膜 (OMM) 需要 PINK1 介导的 PRKN 和泛素的磷酸化 (PubMed:24660806, PubMed:24784582, PubMed:25474007, PubMed:25527291)。线粒体损伤后,VDAC1 与 PINK1 协同作用,通过分别诱导 VDAC1 的多泛素化或单泛素化来介导线粒体自噬或抑制细胞凋亡的选择;VDAC1 的多泛素化促进线粒体自噬,而 VDAC1 的单泛素化则降低线粒体钙离子内流,最终抑制细胞凋亡 (PubMed:27534820, PubMed:32047033)。当细胞应激导致不可逆的线粒体损伤时,通过促进线粒体蛋白 (如 TOMM20、RHOT1/MIRO1、MFN1 和 USP30) 的泛素化,促进功能失调的去极化线粒体的自噬降解 (线粒体自噬)(PubMed:19029340, PubMed:19966284, PubMed:21753002, PubMed:22396657, PubMed:23620051, PubMed:23685073, PubMed:23933751, PubMed:24896179, PubMed:25527291)。优先组装 Lys-6、Lys-11 和 Lys-63 连接的多聚泛素链,从而导致线粒体自噬 (PubMed:25621951, PubMed:32047033)。PINK1-PRKN 通路还通过 PINK1 介导的磷酸化促进受损线粒体的分裂,进而促进 PRKN 依赖性的线粒体分裂相关蛋白 (如 MFN2) 的降解 (PubMed:23620051)。这可以防止不健康的线粒体与线粒体网络重新融合,或启动线粒体碎裂,从而促进其后续被自噬体吞噬 (PubMed:23620051)。通过泛素化及其后续降解 MIRO1 和 MIRO2 来调节受损线粒体的运动性;在运动神经元中,这可能抑制线粒体沿轴突的细胞内顺行运输,从而可能增加线粒体在胞体中发生自噬的几率 (PubMed:22396657)。参与线粒体生物合成,通过转录抑制因子 ZNF746/PARIS 的“Lys-48”连接的多聚泛素化,导致其后续被蛋白酶体降解,并激活转录因子 PPARGC1A (PubMed:21376232)。限制活性氧 (ROS) 的产生 (PubMed:18541373)。在神经元凋亡过程中调节细胞周期蛋白 E (PubMed:12628165)。与 CHPF 亚型 2 协同作用,可能增强细胞活力并保护细胞免受氧化应激损伤 (PubMed:22082830)。独立于其泛素连接酶活性,通过转录抑制 p53/TP53 来防止细胞凋亡 (PubMed:19801972)。可能保护神经元免受 α-突触核蛋白毒性、蛋白酶体功能障碍、GPR37 积累和红藻氨酸诱导的兴奋性毒性损伤 (PubMed:11439185)。可能在突触前末端控制神经递质运输和钙依赖性胞吐中发挥作用。可能是一种抑癌基因 (PubMed:12719539)。
亚细胞定位:细胞质;细胞核;内质网;线粒体;线粒体外膜;细胞突起;突触后致密区;突触前区
表达水平:
组织特异性:在大脑 (包括黑质) 中高表达 (PubMed:19501131, PubMed:9560156) 。在心脏、睾丸和骨骼肌中也有表达 (PubMed:9560156) 。在肿瘤活检组织中表达下调或缺失,在 PARK2 的大脑中也未检测到 (PubMed:12719539, PubMed:14614460) 。过表达可保护多巴胺能神经元免受红藻氨酸介导的细胞凋亡 (PubMed:12628165) 。在血清中可检测到 (蛋白水平) (PubMed:19501131) 。
异构体 & 翻译后修饰:O60260 有 8 种异构体:O60260-1:51641 Da (预测值);O60260-2:48713 Da (预测值);O60260-3:23639 Da (预测值);O60260-4:30616 Da (预测值);O60260-5:42407 Da (预测值);O60260-6:35631 Da (预测值);O60260-7:43485 Da (预测值);O60260-8:46413 Da (预测值)。
ISG 化修饰。在 IFN-β 刺激下与类泛素蛋白 ISG15 结合。 ISGylation 正向调控其 E3 连接酶活性;以 E2 依赖的方式发生自身泛素化,导致自身降解 (PubMed:19229105, PubMed:23770917, PubMed:25474007)。也可被 RNF41 多聚泛素化,进而被蛋白酶体降解 (PubMed:19229105);S-亚硝基化。 PRKN 泛素 E3 连接酶活性的 S-亚硝基化抑制可能通过损害 PRKN 底物的泛素化而促进帕金森病 (PD) 的退行性过程;磷酸化 (PubMed:18957282, PubMed:23754282, PubMed:24660806, PubMed:24784582, PubMed:25474007)。激活需要 PINK1 在 Ser-65 位点磷酸化,并与 PINK1 磷酸化的泛素结合 (PubMed:18957282, PubMed:23754282, PubMed:24660806, PubMed:24784582, PubMed:25474007)。 PINK1 对 Thr-175 和 Thr-217 的磷酸化对于线粒体定位至关重要 (PubMed:18957282)
亚基:与 UBE2L3 或 UBE2L6 形成 E3 泛素连接酶复合物 (PubMed:11078524, PubMed:21532592)。通过与 UBE2V1 结合介导 Lys-63 连接的多聚泛素化。是 SCF 样复合物的组成部分,该复合物由 PRKN、CUL1 和 FBXW7 组成 (PubMed:12628165)。与 SNCAIP 相互作用 (PubMed:11590439, PubMed:15728840)。与 SYT11 的 C2A 和 C2B 结构域结合 (PubMed:12925569)。与 SEPTIN5 相互作用并调节其周转 (PubMed:11078524)。 STUB1、HSP70 和 GPR37 组成的复合物的一部分 (PubMed:12150907)。内质网应激期间,该复合物中 STUB1 的含量增加 (PubMed:12150907)。STUB1 促进 HSP70 从 PRKN 和 GPR37 上解离,从而促进 PRKN 介导的 GPR37 泛素化 (PubMed:12150907)。HSP70 与未折叠的 GPR37 短暂结合并抑制 PRKN 的 E3 泛素连接活性,而 STUB1 通过促进 HSP70 从 PRKN-GPR37 复合物上解离来增强 PRKN 的 E3 泛素连接活性 (PubMed:12150907)。STUB1 与 PSMD4 和 PACRG 相互作用 (PubMed:12634850, PubMed:14532270)。与 LRRK2 相互作用 (PubMed:16352719)。与 RANBP2 相互作用 (PubMed:16332688)。与 SUMO1 相互作用,但不与 SUMO2 相互作用,从而促进核定位和自身泛素化 (PubMed:16955485)。通过第一个 RING 型结构域与 AIMP2 (通过 N 端) 相互作用 (PubMed:16135753)。与 PSMA7 和 RNF41 相互作用 (PubMed:15987638, PubMed:18541373)。与 PINK1 相互作用 (PubMed:19966284, PubMed:20798600)。与 PINK1 和 PARK7 形成复合物 (PubMed:19229105)。与 CHPF 相互作用,与异构体 2 的相互作用可能促进 PRKN 转运至线粒体 (PubMed:22082830)。与磷酸化的 MFN2 相互作用,促进 PRKN 定位于功能异常的去极化线粒体 (PubMed:23620051)。与 FBXO7 相互作用;这促进其易位至功能异常的去极化线粒体 (PubMed:23933751)。与 ZNF746 相互作用 (PubMed:21376232)。与热休克蛋白 70 家族成员相互作用,包括 HSPA1L、HSPA1A 和 HSPA8;与 HSPA1L 的相互作用促进其易位至受损线粒体 (PubMed:24270810)。与 BAG4 相互作用,与 BAG5 的相互作用较弱;与 BAG4 相互作用抑制其向受损线粒体的转位 (PubMed:24270810)。与 PRKN 和 PARK7 形成复合物 (PubMed:19229105)。与 AMBRA1 相互作用 (基于相似性)。
RRID
反应种属数据库
研究领域

Neuroscience

中文名
Parkin 抗体
同用名
AR-JP; LPRS2; PARK2; parkin; parkin 2; PDJ; PRKN; PRKN2
文件资料
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Parkin Antibody
目录号:
HY-P80779
需求量: